CFIDS grant: Presentation of project members

February 23, 2012Media coverage

Breaking Ground Article by K. Kimberly McCleary, about the Research Institute Without Walls. We believe in the power of systematically exploring all drugs and mechanisms for their potential against any disease. We have used this idea as the driving force to create a technologic capability, COSS, that maps and ranks all drugs versus all diseases, side … Read More

Biovista to present at the Drug Repositioning Conference

June 3, 2011Events

CHARLOTTESVILLE, Virginia, June 3, 2011 — Biovista announced today that it is presenting at the Drug Repositioning Conference, San Francisco, on July 13 2011. Biovista’s President, Dr. Aris Persidis, will give a presentation on systematic repositioning using Mechanism of Action. The Drug Repositioning Conference is one of the prime events in this space and has been … Read More

BioWorld: Repurposing: Achilles Heel or Extra Leg to Stand On?

May 9, 2011Media coverage

By Anette Breind, BioWorld Insight For Academia or Industry In the private space, Charlottesville, Va.-based Biovista Inc…Biovista has a positioning program that uses a bioinformatics approach to “develop all reasonable opportunities” for a drug, Persidis said, by tracking “without bias,” all biological effects of a compound…But Biovista is also developing its own in-house pipeline of existing … Read More

Biovista Announces Research Collaboration With a Major Pharmaceutical Company

April 27, 2011Press Releases

CHARLOTTESVILLE, Virginia, April 27, 2011 /PRNewswire/ — Biovista announced today that it has entered into a research collaboration agreement with Novartis. The collaboration is focused on identifying new indications for a number of undisclosed Novartis compounds using Biovista’s Clinical Outcome Search Space (COSS) technology. The terms of the agreement include an upfront payment and success-based … Read More